Seguir
Luisa Lina Villa
Luisa Lina Villa
Professora de Oncologia Básica, Depto Radiologia da Faculdade de Medicina da Universidade de São
E-mail confirmado em hc.fm.usp.br
Título
Citado por
Citado por
Ano
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
Future II Study Group
New England Journal of Medicine 356 (19), 1915-1927, 2007
24252007
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre …
LL Villa, RLR Costa, CA Petta, RP Andrade, KA Ault, AR Giuliano, ...
The lancet oncology 6 (5), 271-278, 2005
23362005
Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer
EL Franco, LL Villa, JP Sobrinho, JM Prado, MC Rousseau, M Désy, ...
The Journal of infectious diseases 180 (5), 1415-1423, 1999
9791999
HPV type-distribution in women with and without cervical neoplastic diseases
G Clifford, S Franceschi, M Diaz, N Muñoz, LL Villa
Vaccine 24, S26-S34, 2006
8972006
Updating the natural history of HPV and anogenital cancer
AB Moscicki, M Schiffman, S Kjaer, LL Villa
Vaccine 24, S42-S51, 2006
8762006
Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia
NF Schlecht, S Kulaga, J Robitaille, S Ferreira, M Santos, RA Miyamura, ...
Jama 286 (24), 3106-3114, 2001
8672001
Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a …
KA Ault
The Lancet 369 (9576), 1861-1868, 2007
8542007
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
LL Villa, RLR Costa, CA Petta, RP Andrade, J Paavonen, OE Iversen, ...
British Journal of Cancer 95 (11), 1459-1466, 2006
7412006
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in …
DR Brown, SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, ...
The Journal of infectious diseases 199 (7), 926-935, 2009
6882009
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
LL Villa, KA Ault, AR Giuliano, RLR Costa, CA Petta, RP Andrade, ...
Vaccine 24 (27-28), 5571-5583, 2006
6812006
Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide …
HU Bernard, SY Chan, MM Manos, CK Ong, LL Villa, H Delius, CL Peyton, ...
Journal of Infectious Diseases 170 (5), 1077-1085, 1994
6401994
Planning cancer control in Latin America and the Caribbean
PE Goss, BL Lee, T Badovinac-Crnjevic, K Strasser-Weippl, ...
The lancet oncology 14 (5), 391-436, 2013
6172013
Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study
AR Giuliano, JH Lee, W Fulp, LL Villa, E Lazcano, MR Papenfuss, ...
The Lancet 377 (9769), 932-940, 2011
5842011
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts …
Future I/II Study Group
The BMJ 341, 2010
5322010
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women
N Muñoz, SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, ...
Journal of the National Cancer Institute 102 (5), 325-339, 2010
4742010
Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia
NF Schlecht, RW Platt, E Duarte-Franco, MC Costa, JP Sobrinho, ...
Journal of the National Cancer Institute 95 (17), 1336-1343, 2003
4522003
Human papillomavirus infections with multiple types and risk of cervical neoplasia
H Trottier, S Mahmud, MC Costa, JP Sobrinho, E Duarte-Franco, ...
Cancer Epidemiology Biomarkers & Prevention 15 (7), 1274-1280, 2006
4392006
The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States
AR Giuliano, E Lazcano-Ponce, LL Villa, R Flores, J Salmeron, JH Lee, ...
Cancer Epidemiology Biomarkers & Prevention 17 (8), 2036-2043, 2008
4322008
An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
JT Schiller, X Castellsagué, LL Villa, A Hildesheim
Vaccine 26, K53-K61, 2008
4182008
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions
SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, CM Wheeler, ...
Cancer prevention research 2 (10), 868-878, 2009
4062009
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20